🇺🇸 FDA
Patent

US 11365195

Atypical inhibitors of monoamine transporters; method of making; and use thereof

granted A61PA61P25/00

Quick answer

US patent 11365195 (Atypical inhibitors of monoamine transporters; method of making; and use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P25/00